Balimbingan, Lita .

HRN: 16-72-89  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/19/2025
CEFTRIAXONE 1G (VIAL)
03/19/2025
03/26/2025
IVT
2 Gm
OD
T/c Partial Mechanical Bowel Obstruction
Waiting Final Action 
03/19/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/19/2025
03/26/2025
IVT
500 Gm
Q 8h
T/c Partial Mechanical Bowel Obstruction
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: